Fingerprint
Dive into the research topics of 'Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule
C. Norman Coleman, Todd H. Wasserman, Raul C. Urtasun, Joanne Halsey, V. Kate Hirst, Steven Hancock, Theodore L. Phillips
Research output: Contribution to journal › Article › peer-review
58
Scopus
citations